Screener / SEC EDGAR /CIK 0001758009 /10-K filed Mar 2, 2026, compared with Mar 20, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Technology · Software

Quantum Computing Inc. QUBT

Compare with peers Embed
The 10-K against last year's

70 changes: 17 added, 12 removed, 39 reworded, 2 quiet changes

10-K Mar 2, 2026 vs Mar 20, 2025

10-K 0001213900-26-022417 (Mar 2, 2026) vs 10-K 0001213900-25-025561 (Mar 20, 2025) Not compared: Accounting Policies.

Every paragraph, and how much of it changed

One bar per paragraph, in the order of the 10-K. Height and colour show the share of its words not in the closest paragraph a year earlier; the tallest bars are new paragraphs.

Risk Factors

158 paragraphs · 9 new · 26 reworded · 7 gone · 10-K Mar 2, 2026 against Mar 20, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 3 · 27% changed Every version of it
QCi was formed in 2018 and merged with QPhoton in June 2022. As a result of our limited operating history, our ability to accurately forecast our future results of operations is limited limited, inherently uncertain and subject to a number of uncertainties, numerous factors outside our control, including our ability to plan for and model future growth. Our ability to generate revenues will largely be dependent on our ability to develop and produce a suite of products based on quantum photonic technologies, with steadily increasing capabilities. Our technical roadmap may not be realized as quickly as hoped, or even at all. As a result, our historical results should not be considered indicative of our future performance. Further, in future periods, our growth could slow or decline for a number of reasons, including but not limited to slowing demand for our quantum products and services, increased competition, changes to technology, our inability to scale up our technology, a decrease in the growth of the market, or our failure, for any reason, to continue to take advantage of growth opportunities. Furthermore, the accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern. We have not emerged from the development stage and may be unable to raise further equity. These factors, among others, that raise substantial doubt about our ability to continue as a going concern may be partially or fully mitigated by the net proceeds received by the Company in conjunction with the sale of 8,163,266 shares of Common Stock (the “PIPE Shares”) issued to the investors pursuant to certain Securities Purchase Agreements dated January 7, 2025. Our financial statements do not include any adjustments that might result from the outcome of this uncertainty or from the sale of the PIPE Shares.
Paragraph 6 · 20% changed Every version of it
We incurred net losses each year since 2018 and we believe that we will expect to continue to incur operating and net losses each quarter until at least for the time foreseeable future and may never achieve or sustain profitability, even if we begin generating significant revenue from our products and services, which may never occur. Even with significant production, we may never become profitable from the sale of our products and services.
Paragraph 144 · 18% changed Every version of it
To regain maintain eligibility to use Form S-3, we must be timely and current in our public reporting for a period of 12 months preceding our intended S-3 filing. While we expect to regain eligibility to use Form S-3 as of September 1, 2025, there reporting. There can be no guarantees that we will remain timely and current in our public reporting through such date. in the future. Should we wish to register the offer and sale of our securities to the public prior to without the time we are eligible ability to use Form S-3, both our transaction costs and the amount of time required to complete the transaction could increase, making it more difficult to execute any such transaction successfully and potentially harming our financial condition.
Paragraph 18 · 16% changed Every version of it
Our success will depend upon business model depends on our ability to expand, expand and scale our operations, operations and to increase our sales and support capability. Even if the market in which we compete meets the size estimates and growth forecasted, our business could fail to grow at similar rates, if at all.
Paragraph 8 · 13% changed Every version of it
We have a history of accumulated deficits, recurring losses and negative cash flows from operating activities. We may be unable to achieve or sustain profitability or remain a going concern. continue operations as planned.
Paragraph 63 · 11% changed Every version of it
Furthermore, our industry generally relies on a limited number of TFLN Optical Chips and wafer manufacturers whose operations tend to be concentrated in China and other parts of East Asia, which makes us especially susceptible to adverse developments in these regions’ economic and political conditions, particularly to the extent that such developments create an unfavorable business environment that significantly affects our operations. Our supply chain could be adversely affected by geopolitical tensions, trade restrictions, export controls, tariffs or changs in United States or foreign government policies affecting cross-border commerce. Although the governments of certain countries, including the United States, have taken actions to make their countries more attractive for chip manufacturing operations, there can be no assurances that the current geographic concentration of chip manufacturing will be meaningfully changed in the near term or at all.
Paragraph 14 · 10% changed Every version of it
Our ability to scale is dependent also upon components that we must source from multiple countries, including China. Our supply chain could be adversely affected by geopolitical tensions, export controls, trade restrictions, tariffs or other changes in U.S. or foreign government policies affecting cross-border commerce. Shortages or supply interruptions in any of these components will adversely impact our ability to generate revenues. Recent tensions between the United States and China have resulted in the U.S.’s imposition of a series of tariffs and other restrictions on imports from China [and and sourcing from certain Chinese persons or entities, as well as other business restrictions. Further, deterioration in the political relationship between the U.S. and China may result in loss of access to suppliers of key components with little or no warning, which would adversely affect our ability to develop and manufacture our products. We are actively searching for alternative suppliers outside of China, including in the United States, but there is no assurance that we can locate comparable components at reasonable prices within the desired timeframes.
Paragraph 26 · 10% changed Every version of it
There can We may be no assurance that unable to obtain additional financing will be available to us on favorable acceptable terms, or at all. all, and any such financing may be dilutive to existing stockholders. The inability to obtain financing when needed may make it more difficult for us to operate our business or implement our growth plans and we may be required to delay, limit or substantially reduce our quantum computing development efforts. Our ability to raise additional capital through the sale of securities could be significantly impacted by the resale of our securities by holders of our securities, which could result in a significant decline in the trading price of our securities and potentially hinder our ability to raise capital on terms that are acceptable to us or at all.

MD&A

51 paragraphs · 8 new · 26 reworded · 5 gone · 10-K Mar 2, 2026 against Mar 20, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 16 · 44% changed
Research and development expenses in 2024 during the year ended December 31, 2025 increased $2.4 $9.2 million or 27% 81% compared with 2023 2024 primarily due to higher employee-related expenses, primarily as a result of headcount and related payroll costs, higher stock-based compensation recurring lab equipment and bonus expenses to incentivize consumables costs, and retain key technologists, as well as higher depreciation for long-lived laboratory equipment, partially offset partially by lower professional hosting services expenses and hosting services. lower stock based compensation expense. The Company is aggressively pursuing its technology roadmap and has hired additional scientists, engineers and technicians in order to accelerate the development of key technologies and products.
Paragraph 2 · 40% changed
The following discussion and analysis of the our financial condition and results of operations and financial condition for the years ended December 31, 2024 and 2023 should be read in conjunction with our consolidated financial statements and the related notes to those consolidated financial statements that are included elsewhere in this Annual Report. Our Report on Form 10-K. This discussion includes contains forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual uncertainties. Our actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number certain factors including, but not limited to, those discussed under Item 1A, “Risk Factors.” The following analysis generally discusses 2025 and 2024 items and year-to-year comparisons between 2025 and 2024. Discussions of factors. See “Forward-Looking Statements.” 2023 items and year-to-year comparisons between 2024 and 2023 that are not included in this Form 10-K can be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the SEC on March 20, 2025.
Paragraph 32 · 38% changed
At December 31, 2024, 2025, we had working capital of $74.6 $1,122.7 million as compared to working capital deficit of $2.2 $74.6 million at December 31, 2023, 2024, an increase of $76.8 $1,048.0 million. The increase in working capital is primarily attributable to an increase in cash and available-for-sale debt securities from the net proceeds of our sales of 16 our sales of 86.3 million shares of common stock for an aggregate of $40 $1,475.1 million in November 2024 and 10 million shares of common stock for an aggregate of $50 million in December 2024, and our issuance of 23.7 million shares of common stock for an aggregate of $23.8 million through the Company’s ATM, as defined below, managed by Ascendiant Capital Markets, LLC during 2024, offset by the use of cash to pay for operating expenses and capital investments in property and equipment. For more information on the November and December issuances, please see Note 10, Capital Stock, in the accompanying notes to our consolidated financial statements appearing elsewhere in this report. 2025.
Paragraph 38 · 36% changed
Net cash provided by financing activities for the years ended December 31, 2025 and 2024 and 2023 was $99.1 $1,477.6 million and $17.7 $99.1 million, respectively. Cash flows provided by financing activities during year ended December 31, 2024 2025 were primarily attributable to net proceeds from our stock issuances in November and December 2024, and the proceeds from our sale of shares of common stock pursuant to the ATM facility and our issuance of the Streeterville Convertible Note, partially offset by repayments on the Streeterville Unsecured Note, as defined below, and the Streeterville Convertible Note as well as redemptions of shares of Series A Preferred Stock. issuances.
Paragraph 12 · 29% changed
Gross margin for the year ended December 31, 2024 2025 was $112 $67 thousand compared to $162 $112 thousand for the prior year, a decrease of $50 $45 thousand, or 31%. 40%. On a percentage basis, gross margin was 30%, 10%, a decrease of 15% 20% year-over-year. The change decrease in gross margin was largely due to higher than anticipated direct labor expenses required to complete the result assembly and test of the first unit of a new custom hardware contract that had lower margins due to its cost product. Cost information from the production of revenues being comprised the first unit will be used in adjusting pricing of other direct component costs in addition to direct labor expenses. subsequent product sales. Our lack of a scaled and distributed base of revenue generation by product and sales channel can result in significant differences in gross margin between reporting periods. We anticipate product gross margins will improve as we build additional units of each product.
Paragraph 37 · 29% changed
Net cash used in investing activities for the years ended December 31, 2025 and 2024 and 2023 was $6.0 $788.3 million and $2.6 $6.0 million, respectively, and was attributable to our purchase of computer hardware, laboratory equipment and TFLN Optical Chips manufacturing equipment for our AZ Chips Facility, equipment, as well as computer hardware and laboratory equipment. The increase in 2024 is primarily due to the purchase of additional equipment $1,197.9 million in connection with establishing the AZ Chip Facility. available-for-sale-debt securities offset by $376.3 million in proceeds from sales of available-for-sale-debt securities.
Paragraph 23 · 23% changed
Year Ended December 31 % 2025 2024 2023 Change Interest and other income income, net $ 20,718 $ 423 $ 295 43% 4,798 Interest expense, net expense (65) (2,496) (1,602) 56% (97 Change in fair value of derivative and warrant liabilities liability 11,750 (40,532) 528 NM 129 Other income (expense) (expense), net $ 32,403 $ (42,605) $ (779) NM (176
Paragraph 26 · 21% changed
Change in fair value of derivative and warrant liability during the year ended December 31, 2025 increased $52,282 or 129% compared with 2024 as a result of the change in the fair value of the QPhoton Warrant Liability (as defined below). The loss on change in value of the warrant liability is entirely a non-cash charge comprised of mark-to-market adjustments for the QPhoton Warrants, as Warrants (as defined below in the accompanying notes to our consolidated financial statements appearing elsewhere in this report, which had no carrying value as of December 31, 2023. below). Future mark-to-market adjustments may result in continued losses if the Company’s stock price of the Company’s common stock increases above the Company’s closing bid price of $16.55 $10.26 per share at on December 31, 2024; 2025; such adjustments may alternatively result in gains if the closing bid share price of the Company’s common stock decreases. See Note 10, 12, Capital Stock, in the accompanying notes to our consolidated financial statements appearing elsewhere in this report for additional information on the QPhoton Warrants. Warrants

A paragraph is matched with the one last year that shares the most of its words; under half in common makes it new. The paragraphs shown are the 8 reworded the most in each section.

The paragraph that changed most in each section

The redline

Marked against last year's 10-K: cut words struck through, new words highlighted.

MD&A151 words changed in this paragraph; it is 30% similar to last year's version.
In addition, interest expense, net, which consists The loss on change in value of interest on financial liabilities and amortization derivative liability is entirely comprised of debt issuance costs, increased $128 thousand or 43% in 2024 compared to 2023, which increase was primarily attributable to interest paid on mark-to-market adjustments for the secured convertible promissory note QPhoton Warrants, as defined below in the original principal amount of $8.25 million that we issued accompanying notes to Streeterville Capital, LLC our consolidated financial statements appearing elsewhere in August 2024 (the “Streeterville Convertible Note”), this report, which we paid in full had no carrying value as of December 31, 2024. 2023. Future mark-to-market adjustments may result in continued losses if the price of the Company’s common stock increases above the closing bid price of $16.55 per share at December 31, 2024; such adjustments may alternatively result in gains if the closing bid share price of the Company’s common stock decreases. See Note 7, Financial Liabilities, 12, Capital Stock, in the accompanying notes to our consolidated financial statements appearing elsewhere in this report for additional information. information on the QPhoton Warrants.

Source: Item 7, 10-K 0001213900-26-022417 vs Item 7, 10-K 0001213900-25-025561

Risk Factors131 words changed in this paragraph; it is 72% similar to last year's version.
QCi was formed in 2018 and merged with QPhoton in June 2022. As a result of our limited operating history, our ability to accurately forecast our future results of operations is limited limited, inherently uncertain and subject to a number of uncertainties, numerous factors outside our control, including our ability to plan for and model future growth. Our ability to generate revenues will largely be dependent on our ability to develop and produce a suite of products based on quantum photonic technologies, with steadily increasing capabilities. Our technical roadmap may not be realized as quickly as hoped, or even at all. As a result, our historical results should not be considered indicative of our future performance. Further, in future periods, our growth could slow or decline for a number of reasons, including but not limited to slowing demand for our quantum products and services, increased competition, changes to technology, our inability to scale up our technology, a decrease in the growth of the market, or our failure, for any reason, to continue to take advantage of growth opportunities. Furthermore, the accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern. We have not emerged from the development stage and may be unable to raise further equity. These factors, among others, that raise substantial doubt about our ability to continue as a going concern may be partially or fully mitigated by the net proceeds received by the Company in conjunction with the sale of 8,163,266 shares of Common Stock (the “PIPE Shares”) issued to the investors pursuant to certain Securities Purchase Agreements dated January 7, 2025. Our financial statements do not include any adjustments that might result from the outcome of this uncertainty or from the sale of the PIPE Shares.

Source: Item 1A, 10-K 0001213900-26-022417 vs Item 1A, 10-K 0001213900-25-025561

Legal Proceedings130 words changed in this paragraph; it is 60% similar to last year's version.
On February 25, 2025, a class action lawsuit was filed against the Company and certain of its current and past officers in the United States New Jersey District Court for the District of New Jersey, Court, by a plaintiff seeking to represent a class of all persons who purchased the Company’s securities between March 30, 2020 and January 15, 2025, alleging violations of Section 10(b) and 20(a) of the Exchange Act. The complaint alleges that the Company made false and/or misleading statements and/or failed to disclose material information about the Company’s customers, contracts and business operations. To date operations in its public statements and SEC filings. The plaintiff seeks unspecified monetary damages plus attorney’s fees and costs. In June 2025, the New Jersey District Court has not certified a class or designated a lead plaintiff. plaintiff who filed an amended operative complaint on or about August 26, 2025. The Company disputes filed a motion to dismiss the allegations in amended operative complaint on November 14, 2025. While the Company’s motion to dismiss was pending, the lead plaintiff filed a motion for leave to file a second amended complaint. The second amended complaint and was subsequently filed on February 13, 2026. The Company intends to vigorously defend against bring a motion to dismiss the asserted claims. second amended complaint. The motion is presently due on or before March 13, 2025.

Source: Item 3, 10-K 0001213900-26-022417 vs Item 3, 10-K 0001213900-25-025561

Sentences and paragraphs added, removed or reworded

Every change, by type

Sentences and paragraphs of QUBT's Risk Factors and MD&A, 10-K Mar 2, 2026 against 10-K Mar 20, 2025. Each links to the text at sec.gov.

Quiet changes are sentences kept from last year with one to four words changed, at least one of them a hedge, a modal or a qualifier (may, could, will, not, significant, material…). A year or date rolling forward is not counted.

The full word list

adverse, adversely, all, although, anticipate, anticipates, any, approximately, believe, believes, can, cannot, certain, could, expect, expects, generally, however, if, intend, intends, largely, likely, many, material, materially, may, might, most, must, never, no, not, possible, primarily, probable, should, significant, significantly, some, substantial, substantially, unlikely, will, would

AddedRisk Factors
In order to grow our business, we may acquire additional assets or companies. For example, we acquired Luminar in February 2026. In connection with these acquisitions or any future acquisitions, there can be no assurance that we will be able to identify, acquire or obtain the required regulatory approvals, or profitably manage the additional businesses or successfully integrate any acquired businesses, products, or technologies without substantial expenses, delays or other operational, regulatory or financial problems. In addition, any acquired businesses, products or technologies may not achieve anticipated revenues and income growth.
Read it in 10-K Mar 2, 2026 at sec.gov
AddedRisk Factors
Further, acquisitions may involve a number of additional risks, including diversion of management’s attention, failure to retain key personnel, or failure to attract the necessary talent to manage organizational growth. We may become responsible for unexpected liabilities that were not discovered or disclosed in the course of due diligence in connection with historical acquisitions and any future acquisitions. Additionally, acquisitions with international operations expose us to greater international business risks. If we do not realize the expected benefits or synergies of an acquisition, such as revenue gains or cost reductions, there could be a material adverse effect on our business, results of operations, and financial condition.
Read it in 10-K Mar 2, 2026 at sec.gov
AddedRisk Factors
We may also seek to divest portions of our businesses which may no longer be aligned with our strategic initiatives and long-term objectives. Various factors could materially affect our ability to successfully do so, including the availability of buyers willing to purchase the assets on terms acceptable to us, difficulties in the separation of operations, the diversion of management’s attention from other business concerns, the disruption of our business, the potential loss of key employees, and the retention of uncertain contingent liabilities related to the divested business. We cannot assure that we will be successful in managing these or any other significant risks that we encounter in divesting a business or product line, and any divestiture we undertake could materially and adversely affect our business, financial condition, results of operations and cash flows.
Read it in 10-K Mar 2, 2026 at sec.gov
AddedRisk Factors
We have identified material weaknesses in our internal control over financial reporting and may identify additional material weaknesses in the future or otherwise fail to maintain an effective system of internal control, which may result in material misstatements of our financial statements or cause us to fail to meet our periodic reporting obligations.
Read it in 10-K Mar 2, 2026 at sec.gov
AddedRisk Factors
We have identified material weaknesses in our internal controls over financial reporting as of December 31, 2024 and 2023. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. Please see Item 9A. Controls and Procedures included elsewhere in this Annual Report for more information about identified material weaknesses.
Read it in 10-K Mar 2, 2026 at sec.gov
AddedRisk Factors
We are in the process of designing and implementing measures to improve our internal controls over financial reporting to remediate the material weaknesses described in Item 9A. Controls and Procedures, primarily by implementing additional review procedures within our accounting and finance department, hiring additional personnel within the Company’s accounting and finance function, designing and implementing information technology and application controls in our financially significant systems, providing internal resources with enhanced access to accounting literature and research materials, engaging additional external accounting experts to supplement our internal resources and increasing communication with third-party professionals with whom we consult regarding the application of accounting standards on complex transactions and instruments.
Read it in 10-K Mar 2, 2026 at sec.gov
AddedRisk Factors
While we are designing and implementing measures to remediate the material weaknesses, we cannot predict the success of such measures or the outcome of our assessment of these measures at this time. We can give no assurance that these measures will remediate the weaknesses in internal control or that additional material weaknesses or significant deficiencies in our internal controls over financial reporting will not be identified in the future. Our failure to implement and maintain effective internal controls over financial reporting could result in errors in our financial statements that may lead to a restatement of our financial statements or cause us to fail to meet our reporting obligations. Further, any failure to implement and maintain effective internal controls over financial reporting, information technology and management processes could adversely affect our financial results and the assessments by our independent registered public accounting firm and their attestation reports, if applicable. Additionally, Astra may not be able to complete our evaluation, testing and any required remediation in a timely fashion. Finally, our current controls and any new controls that we develop may become inadequate because of poor design and changes in our business, including increased complexity resulting from any international expansion.
Read it in 10-K Mar 2, 2026 at sec.gov
AddedRisk Factors
To comply with the requirements of being a public company, we are undertaking various actions and expect to need to undertake additional actions, such as implementing new internal controls and procedures and hiring additional accounting or internal audit staff. Failure to comply with the Sarbanes-Oxley Act could potentially subject us to sanctions or investigations by the SEC, the Nasdaq Stock Market LLC (“Nasdaq”) or other regulatory authorities, which would require additional financial and management resources.
Read it in 10-K Mar 2, 2026 at sec.gov
Show the other 47
AddedRisk Factors
If we are unable to certify the effectiveness of our internal controls, or if our internal controls have material weaknesses, we may not detect errors in a timely manner, our financial statements could be misstated, we could be subject to regulatory scrutiny and a loss of confidence by stakeholders, which could harm our business, financial condition and results of operations and adversely affect the market price of our securities. We may also face litigation as a result of the material weaknesses in our internal control over financial reporting. Any such litigation, whether successful or not, could have a material adverse effect on our business, results of operations and financial condition.
Read it in 10-K Mar 2, 2026 at sec.gov
RemovedRisk Factors
If we fail to establish and maintain an effective system of internal control, we may not be able to report our financial results accurately or prevent fraud. Any inability to report and file our financial results accurately and timely could harm our reputation and adversely impact the trading price of our common stock.
Read it in 10-K Mar 20, 2025 at sec.gov
RemovedRisk Factors
Effective internal control is necessary for us to provide reliable financial reports and prevent fraud. If we cannot provide reliable financial reports or prevent fraud, we may not be able to manage our business as effectively as we would if an effective control environment existed, and our business and reputation with investors may be harmed. As a result, our small size and any current internal control deficiencies may adversely affect our financial condition, results of operations and access to capital.
Read it in 10-K Mar 20, 2025 at sec.gov
RemovedRisk Factors
Subsequent to the issuance of our Annual Report on Form 10-K for the year ended December 31, 2023, and our subsequent retention of BPM LLP to replace BF Borgers CPA PC as our independent registered public accounting firm, management became aware of various adjustments to be recorded to our consolidated financial statements. On September 11, 2024, we filed Amendment 1 to our Annual Report on Form 10-K for the year ended December 31, 2023, restating our financial statements for the years ended December 31, 2023 and 2022 to correct errors primarily related to purchase accounting for the QPhoton Merger, stock-based compensation, and financing costs. We also amended our financial statements for the nine months ended September 30, 2023, in line with the restatement of our annual financial statements. These corrections impacted net loss, goodwill, intangible assets, liabilities, and stockholders’ equity.
Read it in 10-K Mar 20, 2025 at sec.gov
RemovedRisk Factors
These restatements were necessitated in part by deficiencies in our internal control over financial reporting, which management concluded was not effective as of September 30, 2024. Material weaknesses in our controls, including those related to the timely detection and correction of financial reporting errors, coupled with the replacement of our independent auditor, resulted in delayed filings of our Quarterly Reports on Form 10-Q for the periods ended March 31, 2024, and June 30, 2024.
Read it in 10-K Mar 20, 2025 at sec.gov
RemovedRisk Factors
As a result of the failure to timely file our Quarterly Reports on Form 10-Q for the periods ended March 31, 2024 and June 30, 2024, we are currently ineligible to register the offer and sale of our securities using a newly filed registration statement on Form S-3. As of December 31, 2024, we have fully utilized the $100 million “shelf” registration statement on Form S-3 that the SEC declared effective on November 8, 2022.
Read it in 10-K Mar 20, 2025 at sec.gov
RemovedRisk Factors
“Penny stock” rules may make buying or selling our common stock difficult, which may make our stock less liquid and make it harder for investors to buy and sell our securities.
Read it in 10-K Mar 20, 2025 at sec.gov
RemovedRisk Factors
Trading in our common stock has from time to time been and may continue to be subject to the SEC’s “penny stock” rules. The SEC has adopted regulations that generally define a penny stock to be any equity security that has a market price of less than $5.00 per share, subject to certain exceptions. These rules require that any broker-dealer that recommends our common stock to persons other than prior customers and accredited investors must, prior to the sale, make a special written suitability determination for the purchaser and receive the purchaser’s written agreement to execute the transaction. Unless an exception is available, the regulations require the delivery, prior to any transaction involving a penny stock, of a disclosure schedule explaining the penny stock market and the risks associated with trading in the penny stock market. In addition, broker-dealers must disclose commissions payable to both the broker-dealer and the registered representative and current quotations for the securities they offer. The additional burdens imposed upon broker-dealers by these requirements may discourage broker-dealers from effecting transactions in our common stock, which could severely limit the liquidity of, and consequently adversely affect the market price for, our common stock.
Read it in 10-K Mar 20, 2025 at sec.gov
RewordedRisk Factors
We incurred net losses each year since 2018 and we believe that we will expect to continue to incur operating and net losses each quarter until at least for the time foreseeable future and may never achieve or sustain profitability, even if we begin generating significant revenue from our products and services, which may never occur.
Read it in 10-K Mar 2, 2026 at sec.gov
RewordedRisk Factors
While we expect to regain eligibility to use Form S-3 as of September 1, 2025, there There can be no guarantees that we will remain timely and current in our public reporting through such date. in the future.
Read it in 10-K Mar 2, 2026 at sec.gov
RewordedRisk Factors
To regain maintain eligibility to use Form S-3, we must be timely and current in our public reporting for a period of 12 months preceding our intended S-3 filing. reporting.
Read it in 10-K Mar 2, 2026 at sec.gov
RewordedRisk Factors
As a result of our limited operating history, our ability to accurately forecast our future results of operations is limited limited, inherently uncertain and subject to a number of uncertainties, numerous factors outside our control, including our ability to plan for and model future growth.
Read it in 10-K Mar 2, 2026 at sec.gov
RewordedRisk Factors
If we are unable to generate significant revenues in future periods, we will not be able to achieve profitability, and even if we should achieve, achieve profitability, we may be unable to maintain profitability. it.
Read it in 10-K Mar 2, 2026 at sec.gov
RewordedRisk Factors
Our ability to utilize our federal net operating loss carryforwards and other tax attributes to offset future taxable income or tax liabilities may be limited as a result of ownership changes, including potential changes in connection with the QPhoton Merger Merger, the acquisition of Luminar Semiconductor, Inc., or other transactions.
Read it in 10-K Mar 2, 2026 at sec.gov
RewordedRisk Factors
Should we wish to register the offer and sale of our securities to the public prior to without the time we are eligible ability to use Form S-3, both our transaction costs and the amount of time required to complete the transaction could increase, making it more difficult to execute any such transaction successfully and potentially harming our financial condition.
Read it in 10-K Mar 2, 2026 at sec.gov
RewordedRisk Factors
As of March 18, 2025, February 27, 2026, our directors and executive officers collectively beneficially own approximately 20.1% 12.4% of the shares of our common stock including the beneficial ownership of Dr.
Read it in 10-K Mar 2, 2026 at sec.gov
Quiet changesRisk Factors
Our quantum computers are inherently complex and incorporate technology and components that may note not have been used for computing products and that may contain defects and errors, particularly when first introduced.
Read it in 10-K Mar 2, 2026 at sec.gov
AddedMD&A
On December 15, 2025, we entered into a Stock Purchase Agreement (the “Stock Purchase Agreement”) with Luminar Technologies, Inc., a Delaware corporation (the “Seller”) and Luminar, pursuant to which, subject to the terms and conditions set forth in the Stock Purchase Agreement, the Company agreed to acquire all of the issued and outstanding shares of common stock of Luminar from the Seller (the “Luminar Acquisition”) for a total purchase price of $110 million in cash (the “Purchase Price”). The Luminar Acquisition was completed on February 2, 2026. $11.0 million of the Purchase Price was placed with an escrow agent in connection with the signing of the Stock Purchase Agreement. The escrowed amount will remain with the escrow agent to cover certain limited indemnification obligations of the Seller pursuant to the Stock Purchase Agreement until February 2, 2027.
Read it in 10-K Mar 2, 2026 at sec.gov
AddedMD&A
The Seller, together with certain of its subsidiaries, is a debtor in a voluntary Chapter 11 case before the United States Bankruptcy Court for the Southern District of Texas (the “Bankruptcy Court”), which commenced on December 15, 2025. Luminar is not a debtor in such Chapter 11 case and is operating in the ordinary course of business. Upon Bankruptcy Court approval, the Company was designated as the “stalking horse” bidder in connection with a sale of Luminar under Section 363 of the Bankruptcy Code. The Luminar Acquisition was conducted through a Bankruptcy Court-supervised process pursuant to Bankruptcy Court-approved bidding procedures and was subject to the receipt of higher or better offers from competing bidders at an auction, approval of the sale by the Bankruptcy Court, and the satisfaction of certain conditions.
Read it in 10-K Mar 2, 2026 at sec.gov
AddedMD&A
Macroeconomic conditions, including inflation, interest rates and currency fluctuations, have directly and indirectly impacted, and could in the future materially impact, the Company’s results of operations and financial condition. Our business may be affected by disruptions or delays to the federal government budget. We are subject to a lengthy product commercialization timeline and a lengthy sales cycle. Beginning in the second quarter of 2025, new U.S. tariffs were announced, including additional tariffs on imports from China, India, Japan, South Korea, Taiwan, Vietnam and the EU, among others. In response, several countries have imposed, or threatened to impose, reciprocal tariffs on imports from the U.S. and other retaliatory measures. Various modifications to the U.S. tariffs have been announced and further changes could be made in the future, which may include additional sector-based tariffs or other measures. Tariffs and other measures that are applied to the Company’s products or their components can have a material adverse impact on the Company’s business, results of operations and financial condition, including impacting the Company’s supply chain, components, pricing and gross margin. The ultimate impact remains uncertain and will depend on several factors, including whether additional or incremental U.S. tariffs or other measures are announced or imposed, to what extent other countries implement tariffs or other retaliatory measures in response, and the overall magnitude and duration of these measures. Trade and other international disputes can have an adverse impact on the overall macroeconomic environment and result in shifts and reductions in consumer spending and negative consumer sentiment for the Company’s products and services, all of which can further adversely affect the Company’s business and results of operations.
Read it in 10-K Mar 2, 2026 at sec.gov
AddedMD&A
Sales and marketing expenses during the year ended December 31, 2025 increased $1.6 million or 89% compared with 2024 primarily due to increases in the sales staff, higher tradeshow and travel-related costs and increased marketing program costs. During the year ended December 31, 2025 the sales and marketing team participated in 1or 2 conferences and trade shows per month, compared to 1 or 2 trade shows per quarter during 2024, including greater participation in international quantum technology events, resulting in higher travel expenses.
Read it in 10-K Mar 2, 2026 at sec.gov
AddedMD&A
General and administrative expenses during the year ended December 31, 2025 increased $14.3 million or 111% compared with 2024 primarily due to higher employee and advisor-related expenses relating to development and implementation of internal financial controls, expansion of accounting staff, increased recruiting fees and legal expenses related to multiple financings, mergers and acquisition activity, and ongoing litigation.
Read it in 10-K Mar 2, 2026 at sec.gov
AddedMD&A
Interest and other income, net, during the year ended December 31, 2025 increased $20,295 or 4,798% compared with 2024 primarily due to the Company maintaining higher cash balances in mutual funds, deposit and money market accounts, U.S. Treasuries and corporate bonds during as a result of the substantial amount of new funding the Company raised in 2025.
Read it in 10-K Mar 2, 2026 at sec.gov
AddedMD&A
Interest expense during the year ended December 31, 2025 decreased $2,431 or 97% compared with 2024 primarily due to a decrease of interest on financial liabilities as the related borrowings were paid off during 2024. Interest expense during the year ended December 31, 2025 is related to late payroll tax filings.
Read it in 10-K Mar 2, 2026 at sec.gov
AddedMD&A
We believe that our existing cash, cash equivalents and investments will be sufficient to meet our working capital and capital expenditure needs for at least the next twelve months, although we may choose to take advantage of opportunistic capital raising or refinancing transactions at any time.
Read it in 10-K Mar 2, 2026 at sec.gov
RemovedMD&A
You should read the following discussion and analysis of our financial condition and results of operations together with our audited consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K,
Read it in 10-K Mar 20, 2025 at sec.gov
RemovedMD&A
General and administrative expenses in 2024 decreased $2.8 million or 27% compared with 2023 primarily due to lower employee- and advisor-related expenses, including stock-based compensation, payroll, bonus and travel expenses, as well as lower legal fees and consulting services driven by changes made within and by the Company’s management team, offset by increased audit fees driven by the Company retaining a new independent registered public accounting firm in May 2024and such firm’s re-audit of the Company’s consolidated financial statements for the years ended December 31, 2023 and 2022.
Read it in 10-K Mar 20, 2025 at sec.gov
RemovedMD&A
Net selling and marketing expenses in 2024 were largely unchanged as compared with 2023, with increases primarily due to higher stock-based compensation, offset by lower outsourced professional services costs, related marketing program costs, and lower trade show and travel-related costs in 2024.
Read it in 10-K Mar 20, 2025 at sec.gov
RemovedMD&A
Non-operating expense increased to $42.6 million for 2024 compared to $779 thousand for 2023, primarily as the result of a $40.5 million decrease in the change in fair value of the derivative liability for the QPhoton Warrants, as defined below, during 2024 compared to a $528 thousand increase in 2023.
Read it in 10-K Mar 20, 2025 at sec.gov
RemovedMD&A
In addition, interest expense, net, which consists of interest on financial liabilities and amortization of debt issuance costs, increased $128 thousand or 43% in 2024 compared to 2023, which increase was primarily attributable to interest paid on the secured convertible promissory note in the original principal amount of $8.25 million that we issued to Streeterville Capital, LLC in August 2024 (the “Streeterville Convertible Note”), which we paid in full as of December 31, 2024. See Note 7, Financial Liabilities, in the accompanying notes to our consolidated financial statements appearing elsewhere in this report for additional information.
Read it in 10-K Mar 20, 2025 at sec.gov
RewordedMD&A
Operating expenses of approximately $51.1 million during the year ended December 31, 2025 increased as compared to approximately $26.0 million in 2024 decreased as compared to approximately $26.4 million in 2023 primarily as a result of a decrease in higher research and development expenses, sales and marketing expenses and general and administrative expenses, partially offset by an increase in research and development expenses, as set forth in the below tables (in thousands, except percentages).
Read it in 10-K Mar 2, 2026 at sec.gov
RewordedMD&A
Net cash used in investing activities for the years ended December 31, 2025 and 2024 and 2023 was $6.0 $788.3 million and $2.6 $6.0 million, respectively, and was attributable to our purchase of computer hardware, laboratory equipment and TFLN Optical Chips manufacturing equipment for our AZ Chips Facility, equipment, as well as computer hardware and laboratory equipment. the purchase of $1,197.9 million in available-for-sale-debt securities offset by $376.3 million in proceeds from sales of available-for-sale-debt securities.
Read it in 10-K Mar 2, 2026 at sec.gov
RewordedMD&A
The loss on change in value of the warrant liability is entirely a non-cash charge comprised of mark-to-market adjustments for the QPhoton Warrants, as Warrants (as defined below in the accompanying notes to our consolidated financial statements appearing elsewhere in this report, which had no carrying value as of December 31, 2023. below).
Read it in 10-K Mar 2, 2026 at sec.gov
RewordedMD&A
Interest and other income income, net 20,718 423 295 43 4,798 Interest expense, net expense (65) (2,496) (1,602) 56 (97 Change in fair value of warrant liabilities derivative liability 11,750 (40,532) 528 NM 129 Total non-operating income (expense) (expense), net 32,403 (42,605) (779) NM (176 Net loss $ (18,674) $ (68,542) $ (27,022) 154 (73
Read it in 10-K Mar 2, 2026 at sec.gov
RewordedMD&A
Year Ended December 31 % 2025 2024 2023 Change Interest and other income income, net $ 20,718 $ 423 $ 295 43% 4,798 Interest expense, net expense (65) (2,496) (1,602) 56% (97 Change in fair value of derivative and warrant liabilities liability 11,750 (40,532) 528 NM 129 Other income (expense) (expense), net $ 32,403 $ (42,605) $ (779) NM (176
Read it in 10-K Mar 2, 2026 at sec.gov
RewordedMD&A
The following discussion and analysis of the our financial condition and results of operations and financial condition for the years ended December 31, 2024 and 2023 should be read in conjunction with our consolidated financial statements and the related notes to those consolidated financial statements that are included elsewhere in this Annual Report. Report on Form 10-K.
Read it in 10-K Mar 2, 2026 at sec.gov
RewordedMD&A
The increase for 2024 2025 was predominantly driven by primarily due to the increases in direct labor expenses on R&D services contracts and custom hardware contracts, an increase in production overhead, and increased other direct costs (primarily parts and materials) required to perform on the contracts during 2024 the 2025 compared to the prior year.
Read it in 10-K Mar 2, 2026 at sec.gov
RewordedMD&A
Actual Our actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors. certain factors including, but not limited to, those discussed under Item 1A, “Risk Factors.
Read it in 10-K Mar 2, 2026 at sec.gov
RewordedMD&A
We will require a significant amount of cash for continued investment in our Foundry Services offering, including but not limited to future-identified space for expansion of our AZ Chips Facility and any future-identified space for expansion, Facility, as well as the construction or acquisition of a high-volume chip manufacturing facility, as well as ongoing research and development for our non-linear quantum optical products and photonics chips.
Read it in 10-K Mar 2, 2026 at sec.gov
RewordedMD&A
Research and development 20,473 11,318 8,891 27 81 Sales and marketing 3,431 1,818 1,806 1 89 General and administrative 27,240 12,913 15,708 (18 111 Total operating expenses 51,144 26,049 26,405 (1 96 Loss from operations (51,077) (25,937) (26,243) (1 97 Non-operating income and (expense):
Read it in 10-K Mar 2, 2026 at sec.gov
RewordedMD&A
Our This discussion includes contains forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. uncertainties.
Read it in 10-K Mar 2, 2026 at sec.gov
RewordedMD&A
Future mark-to-market adjustments may result in continued losses if the Company’s stock price of the Company’s common stock increases above the Company’s closing bid price of $16.55 $10.26 per share at on December 31, 2024; 2025; such adjustments may alternatively result in gains if the closing bid share price of the Company’s common stock decreases.
Read it in 10-K Mar 2, 2026 at sec.gov

Sources

The two latest 10-Ks on EDGAR, section by section. Each change links to the text at sec.gov.

Also

New risk factors: paragraphs with nothing like them last year, quoted in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/QUBT/export.csv") into a cell.

Next:Related parties
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.